Skip to main
CYRX

CryoPort (CYRX) Stock Forecast & Price Target

CryoPort (CYRX) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 83%
Buy 17%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

CryoPort is well-positioned in a growing market for temperature-controlled supply chain solutions, with a focus on the cell and gene therapy industry. The company's diversified services and products business segments provide multiple revenue streams and potential for cross-selling opportunities. Additionally, the company's strong revenue visibility and potential for margin expansion make it an attractive investment opportunity.

Bears say

CryoPort is a high-growth company that operates in the growing cell and gene therapy market, but is facing tough comps and slowing growth in its Life Sciences Products segment. Furthermore, its valuation seems stretched compared to its peers, and it may struggle to reach profitability in the near term with a low adjusted EBITDA margin. Additionally, upcoming BLA/MAA filings and approvals may provide some potential upside, but overall, we remain cautious on the stock due to these challenges.

CryoPort (CYRX) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 83% of analysts recommend a Strong Buy, 17% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CryoPort and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CryoPort (CYRX) Forecast

Analysts have given CryoPort (CYRX) a Strong Buy based on their latest research and market trends.

According to 6 analysts, CryoPort (CYRX) has a Strong Buy consensus rating as of Sep 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $18.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $18.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CryoPort (CYRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.